Aerie Pharma (AERI) Misses Q4 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.92), $0.05 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $12.94 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Investing.com’s stocks of the week
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings